Category Archives: Hims

Maverick Ventures announces $382M evergreen fund

In an era when validation-seeking venture capitalists are lauded as much as high-flying founders, Maverick Ventures’ small team of investors have opted to stay quiet. Now, the years-old firm is ready to publicize its successes and shed some light on its global strategy. Today, Maverick is disclosing for the first time the size of its evergreen venture fund: a $382 million early-stage vehicle. Launched in 2015 as the venture arm of 25-year-old hedge fund Maverick Capital, San Francisco-based Maverick has funneled cash into direct-to-consumer wellness brand Hims, new-age […]

Read more

iPharmacy Roman fights stigmas with premature ejaculation meds

There’s a war brewing to become the cloud pharmacy for men’s health. Roman, which launched last year offering erectile dysfunctional medication and recently added a ‘quit smoking’ kit, is taking on $97 million-funded Hims for the hair loss market. Today, Roman launched four new products it hopes to cross-sell to users through a unified telemedicine subscription and pill delivery app. It now sells meds for premature ejaculation, oral herpes, genital herpes, and hair loss at what’s often a deep discount versus your local drug store. And for […]

Read more